3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery
Clinical trial NCT07687277 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07687277
- Sponsor
- Lanzhou University Second Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-02-28
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.